Craft

Neptunus

Stock Price

$0.1

2024-07-22

Market Capitalization

$229.9 M

2024-07-22

Revenue

¥1.1 B

FY, 2023

Neptunus Summary

Company Summary

Overview
Neptunus is a biotechnology company that produces and distributes medicines. Its products include herbal medicines, transfusion and antitumor drugs, in-vitro diagnostic reagents, etc. The company offers research and development, and sales services.
Type
Public
Status
Active
Founded
1989
HQ
Shen Zhen Shi, CN | view all locations
Website
http://www.interlong.com
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Shen Zhen Shi, Guang Dong Sheng HQ

    China

    Xiang Gang Li Gong Da Xue Chan Xue Yan Da Lou, 科技园 Nan Shan Qu

Neptunus Financials

Summary Financials

Revenue (FY, 2023)
¥1.1B
Gross profit (FY, 2023)
¥512.2M
Net income (FY, 2023)
¥14.5M
Cash (FY, 2023)
¥372.2M
EBIT (FY, 2023)
¥33.1M
Enterprise value
($43.4M)

Footer menu